Interestingly, one study found that CSF C1q and C3b correlated with NfL levels only in presymptomatic participants, also when adjusting for age, suggesting that complement activation occurs in the late preclinical stage alongside early brain atrophy [8]. The gene discussed is C3; the disease is Brain atrophy.